OVVI Diagnostics is a Belgium start-up founded in 2020 in Liege. It is based on magnetic detection technology taken over from Magnisense: the MIAtek®technology. It is combined with other technologies, such as antibody generation and highly sensitive lateral flow technology, thanks to cooperation with world leaders. OVVI Diagnostics is building a Point-of-Care (POC) testing solution with a panel of tests specifically to address Women’s health issues. Our solution will cover the full spectrum of POC testing needs of women throughout their adult life. Firstly by targeting tests performed by OB/GYN’s either during consultations or in hospital. Secondly with self-testing by the patient or by a nurse at home with results automatically transmitted to the physician. Our Headquarters are located at GIGA, the University of Liège’s interdisciplinary research institute in the biomedical sciences. OVVI Diagnostics France SE is a subsidiary of Ovvi Diagnostics Srl. Our R&D laboratories are located in Dardilly, on the outskirts of Lyon. OVVI Diagnostics France SE is a member of LyonBiopole, the regional cluster for the healthcare and life sciences sector.